Get Ready for Questions About Enerzair for Asthma

Enerzair Breezhaler will be the first "three-in-one" inhaler for adults with asthma.

Enerzair contains the inhaled corticosteroid (ICS) mometasone...the long-acting beta-agonist (LABA) indacaterol...and the long-acting muscarinic antagonist (LAMA) glycopyrronium.

Enerzair seems to improve lung function in asthma patients not controlled on a medium- or high-dose ICS/LABA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote